UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three articles in the prestigious scientific journal, Nature, that ...
Drug discovery increasingly requires sophisticated analysis of proteins, and Thermo Fisher Scientific is building up its capabilities to support such research with the $3.1 billion acquisition of ...
Olink Reveal is more than a proteomics kit—it’s a gateway for anyone starting with proteomics. Whether profiling the reactome or interrogating inflammation biomarkers, validating clinical targets, or ...
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced the introduction of Olink ® Explore HT, a transformational solution for high-throughput proteomics ...
WALTHAM, Mass. & UPPSALA, Sweden--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink ...
Olink® Proteomics, part of Thermo Fisher Scientific is a global biotechnology company dedicated to providing advanced products and services that enable new discoveries into human health and disease.
UPPSALA, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink technology ...
UPPSALA, Sweden, July 03, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, introduces its inaugural network of Olink® Certified Service Providers. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results